Cellectar Biosciences Inc (CLRB)
3.085
+0.04
(+1.48%)
USD |
NASDAQ |
May 31, 16:00
3.085
0.00 (0.00%)
After-Hours: 20:00
Cellectar Biosciences Total Liabilities (Quarterly): 16.74M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 16.74M |
December 31, 2023 | 13.43M |
September 30, 2023 | 34.90M |
June 30, 2023 | 6.976M |
March 31, 2023 | 7.504M |
December 31, 2022 | 6.082M |
September 30, 2022 | 6.569M |
June 30, 2022 | 5.698M |
March 31, 2022 | 4.781M |
December 31, 2021 | 4.157M |
September 30, 2021 | 3.368M |
June 30, 2021 | 3.755M |
March 31, 2021 | 5.289M |
December 31, 2020 | 3.865M |
September 30, 2020 | 4.473M |
June 30, 2020 | 3.867M |
March 31, 2020 | 3.444M |
December 31, 2019 | 3.191M |
September 30, 2019 | 3.428M |
June 30, 2019 | 3.150M |
March 31, 2019 | 2.702M |
December 31, 2018 | 1.793M |
September 30, 2018 | 2.661M |
June 30, 2018 | 2.290M |
March 31, 2018 | 2.109M |
Date | Value |
---|---|
December 31, 2017 | 2.117M |
September 30, 2017 | 2.279M |
June 30, 2017 | 1.737M |
March 31, 2017 | 1.548M |
December 31, 2016 | 1.785M |
September 30, 2016 | 1.579M |
June 30, 2016 | 1.549M |
March 31, 2016 | 2.993M |
December 31, 2015 | 5.947M |
September 30, 2015 | 5.781M |
June 30, 2015 | 6.207M |
March 31, 2015 | 6.323M |
December 31, 2014 | 6.722M |
September 30, 2014 | 2.570M |
June 30, 2014 | 8.429M |
March 31, 2014 | 8.767M |
December 31, 2013 | 5.116M |
September 30, 2013 | 5.221M |
June 30, 2013 | 6.681M |
March 31, 2013 | 7.181M |
December 31, 2012 | 1.320M |
September 30, 2012 | 1.322M |
June 30, 2012 | 1.219M |
March 31, 2012 | 1.087M |
December 31, 2011 | 1.082M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.150M
Minimum
Jun 2019
34.90M
Maximum
Sep 2023
7.234M
Average
4.627M
Median
Total Liabilities (Quarterly) Benchmarks
Perspective Therapeutics Inc | 48.40M |
Eli Lilly and Co | 51.05B |
Actinium Pharmaceuticals Inc | 44.50M |
Altimmune Inc | 15.42M |
GlycoMimetics Inc | 5.294M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 42.91M |
Shareholders Equity (Quarterly) | 26.17M |